NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

大腸癌診斷檢驗的全球市場:醫療設備的開發平台評估

Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020

出版商 GlobalData 商品編碼 366599
出版日期 內容資訊 英文 265 Pages
訂單完成後即時交付
價格
大腸癌診斷檢驗的全球市場:醫療設備的開發平台評估 Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020
出版日期: 2020年11月30日內容資訊: 英文 265 Pages
簡介

本報告提供全球大腸癌診斷檢驗相關產品市場上的主要開發中產品及其臨床實驗的進展調查,再彙整產品功能·特性比較分析 (臨床實驗的各進展階段) ,與主要企業簡介及代表性產品,近來的市場動靜 (業績報告·資本交易趨勢等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 大腸癌診斷檢驗概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各領域
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 開發中產品:現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • 大腸癌診斷檢驗的企業:各臨床實驗階段的開發中產品
  • 大腸癌診斷檢驗:各臨床實驗階段的開發中產品

第5章 大腸癌診斷檢驗市場:企業·產品概要 (全119公司份)

  • A2K Technologies
  • Abbott Diagnostics
  • Abcodia Ltd.
  • Acobiom
  • Advanced Marker Discovery, S.L.
  • Advpharma Inc.
  • Ambergen, Inc.
  • Ambrilia Biopharma Inc.
  • Arizona State University
  • ArtemixRx
  • Asuragen, Inc.
  • Bio Mark Ltd
  • Biocartis SA
  • Biodesix Inc.
  • BioMarCare Technologies Ltd.
  • BioMark Diagnostics Inc.
  • BioMarker Strategies, LLC
  • bioMerieux S.A.
  • Biomoda, Inc. (Inactive)
  • Biosceptre (Aust) Pty Ltd
  • BioSystems International
  • Biotechnostics GmbH
  • BioTime, Inc.
  • Biotron Limited
  • Castle Biosciences Incorporated
  • Cellmid Limited
  • Ceres Nanosciences, Inc.
  • Cernostics Inc.
  • China Sky One Medical, Inc.
  • Chronix Biomedical, Inc.
  • Cleveland Diagnostics Inc.
  • ColoPrev
  • Columbia University
  • Courtagen Life Sciences, Inc.
  • CS-Keys, Inc.
  • Di.V.A.L Toscana srl
  • Diadexus Inc
  • DiagnoCure Inc.
  • Diaxonhit S.A.
  • EDP Biotech Corporation
  • Epigenomics AG
  • Eventus Diagnostics, Inc.
  • Exact Sciences Corporation
  • Exiqon A/S
  • Exosomics Siena SpA
  • Fina Biotech
  • GenomicTree, Inc.
  • Ghent University
  • GlycoZym
  • Health Discovery Corporation
  • Human Metabolome Technologies, Inc.
  • Ikonisys, Inc.
  • InterGenetics Incorporated
  • IV Diagnostics, Inc.
  • John Hopkins University
  • Lab21 Limited
  • Laboratorios Alpha San Ignacio Pharma S.L.
  • Lightsphere Diagnostics
  • LX Diagnostics
  • MabCure Inc.
  • Matrix-Bio, Inc.
  • Max-Delbruck-Centrum fur Molekulare Medizin (MDC)
  • MDNA Life Sciences, Inc.
  • MDxHealth SA
  • Merrimack Pharmaceuticals, Inc.
  • Metabiomics Corporation
  • Metabolomic Technologies Inc.
  • Metabolon, Inc.
  • MetaStat, Inc.
  • Milagen, Inc.
  • Miraculins Inc.
  • Mode Dx Ltd.
  • Moscow Institute of Physics and Technology
  • Myriad Genetics, Inc.
  • Nanosphere, Inc.
  • NetScientific Plc
  • Norda ASA
  • Novel Bio-spectrum Technologies, Inc.
  • Nuclea Biotechnologies Inc.
  • Nuvera Biosciences, Inc.
  • Oncimmune (USA) LLC
  • OncoVista Innovative Therapies, Inc.
  • On-Q-ity, Inc. (Inactive)
  • Origin Sciences Limited
  • Orion Genomics LLC
  • OTraces Inc.
  • Oxford Cancer Biomarkers
  • Oxford Gene Technology Limited
  • Panacea Pharmaceuticals, Inc.
  • PleX Diagnostics
  • Precision Biologics, Inc.
  • Prediction Sciences
  • Protagen AG
  • Rabin Medical Center
  • Rosetta Genomics Ltd
  • Scienion AG
  • Seegene, Inc.
  • Shuwen Biotech Co. Ltd.
  • Siamab Therapeutics, Inc.
  • Skuldtech France
  • Sysmex
  • Tel Aviv University
  • The Chinese University of Hong Kong
  • The Walter and Eliza Hall Institute of Medical Research
  • TheraDiag SA
  • Theranostics Health, Inc.
  • Todos Medical Company Overview
  • Universal Diagnostics, S. L.
  • Universite De Lyon
  • University of Alabama at Birmingham
  • University of Illinois at Chicago
  • University of Texas at Austin
  • US Biomarkers, Inc.
  • Vanderbilt University
  • Vermillion, Inc.
  • Viomics Inc.
  • Vitatex Inc.
  • VolitionRX Ltd.
  • XEPTAGEN SpA

第6章 大腸癌診斷檢驗市場市場:目前的趨勢 (全99件)

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME1030EPD

GlobalData's Medical Devices sector report, "Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Colorectal Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Colorectal Cancer Diagnostic Tests are used for detection of CRC based on the detection and measurement of cancer-specific biomarker/antibody/antigen present in patient's sample.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Colorectal Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Colorectal Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Colorectal Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Colorectal Cancer Overview

3 Products under Development

  • 3.1 Colorectal Cancer - Pipeline Products by Stage of Development
  • 3.2 Colorectal Cancer - Pipeline Products by Territory
  • 3.3 Colorectal Cancer - Pipeline Products by Regulatory Path
  • 3.4 Colorectal Cancer - Pipeline Products by Estimated Approval Date
  • 3.5 Colorectal Cancer - Ongoing Clinical Trials

4 Colorectal Cancer - Pipeline Products under Development by Companies

  • 4.1 Colorectal Cancer Companies - Pipeline Products by Stage of Development
  • 4.2 Colorectal Cancer - Pipeline Products by Stage of Development

5 Colorectal Cancer Companies and Product Overview

6 Colorectal Cancer- Recent Developments 1887 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

List of Tables

  • Table 1: Colorectal Cancer - Pipeline Products by Stage of Development
  • Table 2: Colorectal Cancer - Pipeline Products by Territory
  • Table 3: Colorectal Cancer - Pipeline Products by Regulatory Path
  • Table 4: Colorectal Cancer - Pipeline Produ

List of Figures

List of Figures

  • Figure 1: Colorectal Cancer - Pipeline Products by Stage of Development
  • Figure 2: Colorectal Cancer - Pipeline Products by Territory
  • Figure 3: Colorectal Cancer - Pipeline Products by Regulatory Path
  • Figure 4: Colorectal Cancer - Pipeline